TANDEM DIABETES CARE INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.0 | $0.9 | $0.7 | $0.8 | $0.7 |
| Operating income | -$0.2 | -$0.1 | -$0.2 | -$0.1 | $<0.1 |
| Net income | -$0.2 | -$0.1 | -$0.2 | -$0.1 | $<0.1 |
| Cash Flow Statement | |||||
| Free cash flow | -$<0.1 | $<0.1 | -$0.1 | $<0.1 | $0.1 |
| Share repurchases | $0.0 | $<0.1 | $0.0 | $0.0 | — |
Shares outstanding 68.5M · Free float 93.0%
Annual filing data through FY ended December 31, 2025; float as of August 29, 2026.